119 related articles for article (PubMed ID: 7787011)
21. Treatment for adult acute myeloid leukemia: where we stand in 1995.
Wiernik PH
Acta Haematol Pol; 1995; 26(3):231-7. PubMed ID: 8525767
[No Abstract] [Full Text] [Related]
22. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
[TBL] [Abstract][Full Text] [Related]
23. Testing for the presence of immune or cured individuals in censored survival data.
Maller RA; Zhou S
Biometrics; 1995 Dec; 51(4):1197-205. PubMed ID: 8589219
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
[TBL] [Abstract][Full Text] [Related]
25. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H
Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664
[TBL] [Abstract][Full Text] [Related]
26. A method for sequential analysis of survival data with nonproportional hazards.
Sooriyarachchi MR; Whitehead J
Biometrics; 1998 Sep; 54(3):1072-84. PubMed ID: 9750253
[TBL] [Abstract][Full Text] [Related]
27. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
Brunet S; Esteve J; Berlanga J; Ribera JM; Bueno J; Martí JM; Bargay J; Guardia R; Juliá A; Granena A; Montserrat E; Sierra J;
Haematologica; 2004 Aug; 89(8):940-9. PubMed ID: 15339677
[TBL] [Abstract][Full Text] [Related]
28. Comparison of meta-analysis versus analysis of variance of individual patient data.
Olkin I; Sampson A
Biometrics; 1998 Mar; 54(1):317-22. PubMed ID: 9544524
[TBL] [Abstract][Full Text] [Related]
29. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
Moodie PF; Nelson NA; Koch GG
Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
[TBL] [Abstract][Full Text] [Related]
30. Parametric models for accelerated and long-term survival: a comment on proportional hazards.
Frankel P; Longmate J
Stat Med; 2002 Nov; 21(21):3279-89. PubMed ID: 12375304
[TBL] [Abstract][Full Text] [Related]
31. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
32. Treatment of leukemia with partially matched related bone marrow transplantation.
Munn RK; Henslee-Downey PJ; Romond EH; Marciniak EJ; Fleming DR; Messino MJ; Macdonald JS; Rayens MK; Harder EJ; Phillips GL; Thompson JS
Bone Marrow Transplant; 1997 Mar; 19(5):421-7. PubMed ID: 9052906
[TBL] [Abstract][Full Text] [Related]
33. Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis.
Hartman AR; Williams SF; Dillon JJ
Bone Marrow Transplant; 1998 Sep; 22(5):439-43. PubMed ID: 9733266
[TBL] [Abstract][Full Text] [Related]
34. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
35. Time-dependent effects of fixed covariates in Cox regression.
Verweij PJ; van Houwelingen HC
Biometrics; 1995 Dec; 51(4):1550-6. PubMed ID: 8589239
[TBL] [Abstract][Full Text] [Related]
36. Intensified induction therapy for children with AML.
Woods WG
Ann Hematol; 2004; 83 Suppl 1():S119-20. PubMed ID: 15124701
[No Abstract] [Full Text] [Related]
37. Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
[No Abstract] [Full Text] [Related]
38. [Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A; Bellini P; Terracini B;
Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).
Copelan EA; Biggs JC; Szer J; Thompson JM; Crilley P; Brodsky I; Klein JL; Kapoor N; Harman GS; Avalos BR
Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074
[TBL] [Abstract][Full Text] [Related]
40. Influence diagnostics for generalized linear measurement error models.
Zhao Y; Lee AH; Hui YV
Biometrics; 1994 Dec; 50(4):1117-28. PubMed ID: 7786992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
